Interventional Oncology: A Boon for Patients Dealing with Various Forms of Cancers

Nowadays, cancer is becoming one of the most common diseases among people all across the globe. The increasing number of cases suffering from various cancers is the challenging part for medical professionals to help patients overcome the severity of the disease. Previously, cancer therapies include surgeries, chemotherapy, and radiation techniques. All these procedures are risky, and time-taking and make patients suffer economically, emotionally, and physically. With the continuous research and development activities in the field of cancers, the branches of medicine have come up with the newest and most advanced method of cancer treatment called “interventional oncology”.

Interventional oncology is a sub-specialty of radiology therapy that includes negligible invasive procedures for the diagnosis and treatment of various forms of cancers. Interventional oncology is treated as the fourth pillar of cancer care that supports medical, surgical, and radiation oncology. Mostly, this type of interventional oncology uses image-guided procedures that enable oncologists to reach difficult parts of the body in a minimally invasive manner. This reduces the risks and complications associated with the procedures and provides patients with the fastest and safest way to deal with chronic disease.

What is the Basic Difference Between Interventional Oncology and Conventional Cancer Therapies?

Historically, conventional cancer therapies have been performed in an inpatient hospital setting. In this setting, patients have to be admitted to the hospitals and undergo lots of procedures including surgeries, taking numbers of chemo depending on the severity of the disease, and even radiations. However, with interventional oncology, patients can be offered an outpatient clinic setting. This model is much beneficial to the patients as it eliminates the stress of going to hospitals to perform the procedures. The outpatient clinic setting is more beneficial to patients as it provides both financial and emotional support to them. This kind of personalized care to the patients has increased the demand for interventional oncology in recent years.

What are the Benefits of Interventional Oncology?

Interventional oncology has been treated as the most evolved technology in the field of cancer care that not only helps patients to overcome the difficult times with ease but also help oncologists to perform complex procedures less invasively. Some of the major benefits of interventional oncology are discussed below:

• Interventional technology includes its own set of technologies and clinical acumen which has enhanced the comfort level of treating patients as compared to the previous therapies for cancers.
   
• Interventional oncologists are trained in how to manage the medical and perioperative needs of patients in an outpatient setting.
   
• Interventional oncology helps cancer treatment providers as well as patients to reduce the cost associated with the procedures and the demand for resources.
   
• The financial burden has always become a vital obstacle for the families of patients undergoing treatment for cancers. Standing in a queue for reimbursement, and dealing with medical insurance companies have remained a challenging task for the patient’s family members during the outpatient care. However, in interventional oncology patients are benefitted from cheaper procedures.
   
• Interventional oncology provides targeted, and personalized medicines to patients with curative and palliative intent.
   
• It provides improved patient outcomes with fewer complications, shorter hospitalization, faster recovery, cost-effective treatment options, and personalized patient care.

The Future Landscape of the Interventional Oncology Market

With the increasing number of cancer cases among individuals worldwide, the global interventional oncology market is expected to witness significant growth in the approaching years. The market is anticipated to generate a revenue of $3,791.50 million and grow at a CAGR of 6.5% during the analysis period from 2022 to 2030. However, the lack of information regarding interventional oncology in middle or low-income regions may impede the growth of the market in the upcoming future.

The Bottom Line

The rigorous expansion of healthcare equipment and hospitals with advanced facilities across many nations all around the world to help individuals avail best services is expected to boost the growth of the interventional oncology market in the ahead years. Furthermore, the increasing demand for personalized medical care and growing disposable incomes among people are the factors expected to boost the demand for interventional oncology with greater intensity.

About the Author(s)

Princy A. J

Princy holds a bachelor’s degree in Civil Engineering from the prestigious Tamil Nadu Dr. M.G.R. University at Chennai, India. After a successful academic record, she pursued her passion for writing. A thorough professional and enthusiastic writer, she enjoys writing on various categories and advancements in the global industries. She plays an instrumental role in writing about current updates, news, blogs, and trends.